<SEC-DOCUMENT>0001564590-14-000556.txt : 20140304
<SEC-HEADER>0001564590-14-000556.hdr.sgml : 20140304
<ACCEPTANCE-DATETIME>20140304164500
ACCESSION NUMBER:		0001564590-14-000556
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20140303
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20140304
DATE AS OF CHANGE:		20140304

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34207
		FILM NUMBER:		14665486

	BUSINESS ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>dvax-8k_20140303.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
<body>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="border-top:Solid 0.75pt;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:1pt;line-height:1pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:4pt;font-family:Times New Roman;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;border-top:Solid 1pt;margin-top:1pt;line-height:1pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:4pt;font-family:Times New Roman;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:4pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:18pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:18pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549 </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:18pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form 8-K </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:10pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported):&#160;03/3/2014 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:24pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Technologies Corporation </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter) </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:10pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Commission File Number:&#160;001-34207 </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Delaware</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">33-0728374</font></p></td>
</tr>
<tr>
<td valign="top" style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction</font></p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of incorporation)</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer</font></p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</font></p></td>
</tr>
</table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2929 Seventh Street, Suite 100 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Berkeley, CA 94710-2753 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:8pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices, including zip code) </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(510) 848-5100 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:8pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Registrant&#8217;s telephone number, including area code) </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report) </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:10pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:12pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Wingdings'">&#168;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:12pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:12pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Wingdings'">&#168;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:12pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Wingdings'">&#168;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:12pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Wingdings'">&#168;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:12pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </font></p></td></tr></table></div><p style="border-top:Solid 0.75pt;margin-bottom:0pt;margin-top:8pt;text-align:center;line-height:1pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:4pt;font-family:Times New Roman;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;border-top:Solid 1pt;margin-top:1pt;line-height:1pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:4pt;font-family:Times New Roman;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Item 2.02.&#160;&#160;&#160;&#160;Results of Operations and Financial Condition</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:5.15%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.15%">On March</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3, 2014, we issued a press release titled "Dynavax to Receive $5.4 Million Milestone." A copy of the press release is attached as Exhibit 99.1 to this current report and is incorporated herein by reference. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">(d) Exhibits. The following exhibit is furnished herewith: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">99.1 Press Release, dated March</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3, 2014 titled "Dynavax to Receive $5.4 Million Milestone." </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td colspan="3" valign="top" style="width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="top" style="width:3%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="top" style="width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Technologies Corporation </font></p></td>
</tr>
<tr>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Da&nbsp;&nbsp;Date: March 4, 2014 </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="top" style="width:3%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="top" style="width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;&#160;&#160;/s/ &#160;David Johnson</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
</tr>
<tr>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Johnson</font></p></td>
</tr>
<tr>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="middle" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p></td>
<td valign="bottom" style="width:53%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice President </font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT INDEX </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:auto; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<br>No.</font></p></td>
<td valign="bottom" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:auto; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</font></p></td>
</tr>
<tr>
<td valign="top" style="width:auto; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EX-99.1</font></p></td>
<td valign="bottom" style="width:auto; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="top" style="width:auto; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax To Receive $5.4 Million Milestone.</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>dvax-ex99_201403036.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
<body>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0.93%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</font></p><p style="text-align:right;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><img src="g201403042042151301766.jpg" alt="logo" style="width:160.5pt;height:47.25pt"><font style="color:#0000FF;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Calibri;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;color:#145590;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">2929 Seventh Street, Suite 100&#160;&#160;&#160;&#160;&#160;&#160;</font></p><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Calibri;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;color:#145590;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Berkeley, CA 94710&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Contact:</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:11pt;;"><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael Ostrach</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:11pt;;"><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Business and Principal Financial Officer</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:11pt;;"><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">510-665-7257</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:11pt;;"><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">mostrach@dynavax.com</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial Bold;font-weight:bold;;font-size:11pt;;"><a name="OLE_LINK9"></a><font style="font-weight:bold;font-size:11pt;font-family:Arial Bold;text-transform:uppercase;font-style:normal;font-variant: normal;">DYNAVAX To Receive $5.4 Million MILESTONE </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">AstraZeneca to Assume Responsibility for Future Clinical Development</font><font style="font-weight:bold;font-size:11pt;font-family:Arial Bold;text-transform:uppercase;font-style:normal;font-variant: normal;"> </font><font style="font-weight:bold;font-size:11pt;font-family:Arial Bold;font-style:normal;text-transform:none;font-variant: normal;">of Investigational TLR-9 Agonist for Treatment of Asthma</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:11pt;;"><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BERKELEY, CA &#8211; March 3, 2014 &#8211; Dynavax Technologies Corp. (NASDAQ: DVAX) today announced a $5.4 million milestone payment from its collaborator, AstraZeneca. The companies also amended their research collaboration and license agreement to transfer responsibility for conduct of further clinical trials from Dynavax to AstraZeneca, following completion of the ongoing Phase 1 clinical study of AZD1419 for the treatment of asthma. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:11pt;;"><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2013 dosing began in a Phase 1 study to assess the safety of inhaled doses of AZD1419 in up to 45 healthy subjects, to be followed by up to 24 patients with mild asthma. Remaining potential milestone payments to Dynavax total approximately $100 million. In addition, Dynavax will receive royalties on worldwide sales of any approved products and will have the opportunity to co-promote in the United States.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">About Dynavax</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:11pt;;"><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. Dynavax's lead product candidate is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine. For more information visit </font><font style="text-decoration:underline;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">www.dynavax.com</font><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">About AstraZeneca</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:11pt;;"><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Forward Looking Statements</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:11pt;;"><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This press release contains "forward-looking statements," including statements related to expected payments under our AstraZeneca agreement. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in our business, including whether results of completed studies can be replicated in human studies, difficulties or delays in discovery or development, initiation and completion of preclinical or clinical studies, the results of those studies and the impact of those results on the initiation and completion of subsequent studies and issues arising in the regulatory process; achieving our AstraZeneca agreement objectives; our ability to obtain additional financing to support our operations; and other risks detailed in the "Risk Factors" section of our current periodic reports filed with the SEC. We undertake no obligation to revise or update information herein to reflect events or circumstances in the future, even if new information becomes available. Information on Dynavax's website at www.dynavax.com is not incorporated by reference in the Company's current periodic reports with the SEC.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:11pt;font-family:Arial;"><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"># # #</font></p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g201403042042151301766.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g201403042042151301766.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`$9`Z<#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`**9+-%"`994C!Z%V`S6?+XAT:#[^IVO7&%E#'
M]*`-.BL%_&?A]&*G41D>D3D?F%JM_P`)]H?_`#TG_P"_1H"YT]%<G)\0]&1L
M+%>2#^\L:X_5A3/^%C:1_P`^U]_WPG_Q5`7.OHKD/^%C:1_S[7W_`'PG_P`5
M4D7Q"T:0D,EW'CNT8Y_(F@+G5T5S<?CO07;#7$D8QU:)L?IFKL'BC0[C&S4X
M!G_GH=G_`*%B@#7HIJ2)*@>-U=3T93D&G4`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`'G_B'QOJ-EJES8VD4$:Q-M\Q@68_T_2N6N?$>LW>?-U*XP<Y
M"/L!S[+@5U6J^!]1U37+N[$UO%!+(2NYB6QCT`_K3(?AK*2?.U-%';9$6S^9
M&*9.IPKNTC%G8LQZDG)-)79Z]X%&F:9+>VUXTHB`+QNH!(SU!_I7&4P"BBB@
M04^*&68D11/(1U"J3BO0/`&EV%SI4UU<6D,LZW!17D4-@!5(QGIR>M=RB+&@
M5%"J.@`P!2N.QX7]AO/^?6?_`+]FHY8)H,>;$\>>F]2,U[S2,H=2K`%2,$$<
M$47'8\#HKV:^\,:-J`/G6,2N>=\0V-^G7\:X_5_A[<0`RZ7-]H0?\LI"`_X'
MH?THN*QQ]M>7-G)YEM<2POZQN5/Z5T^F?$#4K3"7J)>1CN?D?\QQ^8_&N4DB
MDAE:.5&213AE88(/H13:8'LVC^)--UL;;:7;/C)ADX8?X_A6O7@:.T;JZ,59
M3D,#@@^M=[X9\<G*6>L2<=$N3_)O\?S]:5AIG?T4`@@$'(/0BBD,****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`R/%/_(KZA_UR/\Z\9KV;Q3_R*^H?]<C_`#KQ
MFFB6%%%%,1Z=\.?^1>N/^OIO_0$KKZY#X<_\B]<?]?3?^@)77U):"BBB@`HH
MHH`P_$7AFUUVW+86*\4?NYL?HWJ/Y5Y+>6=QI]W):W49CFC.&4_S^E>[5ROC
M7P^NI:<U[`G^EVRD\=73N/?'4?CZTT)H\LHHHIDG:^#?%C6LD>F7\G^C-Q%*
MQ_U9]"?3^7TZ>D5X%7J/@CQ`VIV365R^ZZMQP3U=.F3[@\?E2929UE%%%(84
M5YGK_B[6K37;RWMKORH8I"BKY2'@?4&L]/&_B!6!-\&`_A,*8/Y"G85SURBO
M*D\?ZXA4LUNX'4-%U_(BK*?$;5`X,EK9LO<*K`_GN-%@N>F45YS_`,+)O/\`
MH'P?]]FD;XD7I4[;"W#8X)9B,T6"YZ/17GVC>-]3U+7+.UFCMDBD?:PC0@G(
M]237H-(84444`%%<9XT\0:EHU_:+93A$>,LRE%8,<^XS7.?\)]KG_/2#_OT*
M=A7/5J*\S3XC:H'!DM;-E[A58'\]QHD^(^J%OW=I9JOHP8G\]PHL%STRBN2\
M)>)K[7KRYCND@18HPP$2D<Y]R:ZVD,**\OO/'&N6][/#NA7RY&3!BY&#BH3X
M]UT@CS81[^4*=A7/5J*\H3QYKJJ`9H6(_B,0R?RI)/'>O.N%N(HS_>6)<_KF
MBP7/6**\IL_'>M07<<ES.+B$'YXC&BY'U`R#7I6FZG::M:+<V<H=#P1W4^A'
M8T@N7****!A1110`4444`%%>5O\`$#6W<LIMD!_A6/@?F33'\>:ZRD":%2?X
MA$,C\Z=A7/5Z*\A_X37Q#_T$/_(,?_Q-12>+=>E?<VI2@_[(51^0%%@N>QT5
MY#9>)=<FO[>,ZA.X:105]1FO7J07"BBB@84444`%%%%`!17B_B34O[5UZZN5
M;,>[9'Z;1P,?7K^-+X:U0Z3KMO<%ML3'RY?38>N?IP?PIV%<]GHHHI#"BBB@
M`HK@?B!J%[97UFMK>7$"M$21%*R@G/L:Y:+Q1KD(4+J=P=IR-[;OSSG-.PKG
ML]%>0_\`":^(?^@A_P"08_\`XFK`\>ZZ`!YL)]_*%%@N>K45Y0_CS764@30J
M3_$(AD?G59_&7B"1"K:BP!_NQHI_,"BP7/8**\4D\0ZS(VYM4O`?]F9E'Y`U
MZ%X"N[F\T*>2ZN)9W%RRAI7+$#:O&3]:+!<ZFBBN*^($M]!_9TUF]Q'L\W>\
M)8;?N]2/Q_6D,[6BO%HO$FM1`A=4NCG^](6_G5I?&GB!5"C4#@#',2$_GMIV
M%<]?HKR'_A-?$/\`T$/_`"#'_P#$U#-XLUV?._4I1D8^0!/_`$$#\Z+!<]DH
MKS#P?<:M?^([66:>]N+:+?O=W9T7*'&2>!SBO3Z0PHHHH`***\[^(VI"2YMM
M-0\1#S9.>,G@#Z@9_P"^J`/1**\$C=HI%D1BKJ0RL.H(KVS1=175='MKT?>D
M3YQZ,.&'Y@T"3+]%%%`PHHHH`****`"BF3>9Y,GE8\S:=N>F>U>2?\)KXA_Z
M"'_D&/\`^)H%<]>HKR(>-O$((/V_/MY,?_Q-7(_B'K*+AHK.0_WFC;/Z,*=@
MN>HT5YPOQ(O0HW6%N6QR0S`9J.7XCZD2/*L[11WW!F_J*+!<]+HKRN7X@:W(
M<K]FBXQA(_UY)K8\&>(-6U?6I(+V\\R)(&DV^6@R<J.H`/>BP7.\HHK@O%'B
M[4=+UV6SLY(O+C5<AH\D$C/7\12&=[17E/\`PGVN?\](/^_0H_X3[7/^>D'_
M`'Z%.PKGJU%>8#XBZP`!]GLC[E&_^*J.7X@ZU(056UCQV6,\_F318+GJ=%>?
M^$/$NK:GKJVUY=>;"8V.WRU7D>X`KT"D,****`"BBB@`HHHH`****`"BBB@#
M(\4_\BOJ'_7(_P`Z\9KV;Q3_`,BOJ'_7(_SKQFFB6%%%%,1Z=\.?^1>N/^OI
MO_0$KKZXOX;R$Z3=Q8&U9]P]<E1_@*[2I+04444`%%%%`!1110!XYXJTI=(U
MZ:",8AD_>Q#T4]OP((_"L6O1OB/9;[&TOE',<AC8CT89'ZC]:\YIDL*N:5J$
MFE:G!>Q=8FR1_>'<?B*IT4Q'O4,R7$$<T;;HY%#J?4$9%/KE_`5_]K\.B!C\
M]LYC_P"`GD?S(_"NHJ2R&XL[6[7;<VT,P])$#?SKA/%W@Z&WMFU'2XMB1C,T
M(R0!_>'T[BO0:"`001D'J#0!X%170^+]"_L75=T*XM+C+Q8Z*>Z_A_(USU40
M%>CZ9X$T>YM(;HW5S<)*H=<$("".XP3G\:\XKNO`&N^5*VD7#`(Y+P,3T;NO
MX]?S]:3&CK;#PSH^FR)+;62"5>DCDL0?7D\?A6M112*"BBB@"K>:;9:@`+RT
MAGP,`R("1]#VKF/$/A?0++1;N\6W,$B(61DD;ES]T8)(QDBNQKS/Q[K9N[\:
M9"W[FV.9,'AG_P#K?U-`F<>B-(ZHBEF8X"@9)/I7H&B_#Z(P1SZM(YD89,$9
MP%]B>_X8IG@'0/\`F,W*>JVZG\BW]!^/M7?TVP2*.GZ-I^E;OL-JD)8`,1DD
MCZGFKU%%(9FW>@:3?%FN-/MV=R2SA-K$GN2.:Y[5?A[931.^FR/;R@?+&[;D
M/MSR/KDUV=%`'A-Y9W&GW<EK=1F.:,X93_/Z5!7H'Q)M$V6-X%P^6B8XZCJ.
M?;G\Z\_JB0K2T76KK0[X7%N<J>)(R?E<>A_H:S:*!'M^E:K:ZS8K=6KY4\,I
M^\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*
M3+U%%%`PHHHH`R;OPSHMZQ:?3H=QZE`4)_[YQ7,Z]X#LX-/GO-/EE1X4,AB<
M[@P`R0#U!_.N\JO?_P#(/N?^N3?R-`K'A5>@^&_`UM):0WVIGS?-0.D"D@`$
M9&3US[?SKSZO;M$8MH&G,Q)8VL1))Y)VBFQ(EL]-LK`8M+2&#(P2B`$_4]ZM
M444B@HHHH`****`"L7Q7J1TOP]<RH<2R#RH^<<MQD>X&3^%;5>;?$34?.U*#
M3T(VVZ;WP?XF['Z`#\Z!,XNBBBJ)/7_!^J#4_#T&YLS0#R9,]>.A_$8Y]<UO
M5Y;X"U3[%K9M'/[J[&WKT<<C^H_$5ZE4E(****!D-Q:6UVFRYMXIE_NR(&'Z
MUC:AX.T6^B8+:+;R'.V2'Y<'Z=/TK?HH`\-U+3YM*U":RN`/,C.,CH1V(JI7
MH?Q$T@R0PZM$.8\13?[I/RG\SC\17GE,EA75^#/#5KK;3W%ZS-#"P41*<;B?
M4^GTKE*ZOP#J7V/73:N<1W:;?^!#D?U'XT`CT2#1M,MAB'3[5.,9$2Y/U/>K
MU%%(H****`*UQI]E=AOM%I!+NZ[XP<_G7F?C70K/1KRW:R^1)U8F(MG:01R.
M^#G]#7JM>2^-]0^W>))45LQVP$*\\9'+?J2/PIH3,"""6YN(X(4+RR,%11W)
MKT_2/`NFV*))>+]KN!@G?]P'V7N/K7/_``]TK[1J,NI2#]W;C8GNY']!_,5Z
M50P2&QQI%&J1HJ(HP%48`%.HHI#"BBB@!LDB11M([!44%F8]`!7B&JW[ZGJE
MS>OG,KE@#V'0#\!@5Z9XXU+[!X>>)&Q+='RACKM_B_3C\:\GIHEA7=_#K5-D
MMQIDC</^]BR>XX8?E@_@:X2K>F7TFF:G;WL>=T+AB!W'<?B,C\:8'N5%,AF2
MX@CFC;='(H=3Z@C(I]24%%%%`!1110`5DS^&-$N,[],MQD8_=KL_]!Q6M10!
MY_K_`(!2&WDNM)=R4&YK=SG([[3_`$/Y]JX*O?:\O\;^'O[.O/[0MU_T6X;Y
M@!_JW]/H>3^?M30FCDJ***9)Z3X:\,>'[_1[:\,+7$C*/,WR'Y7'WA@8XSZ]
ML5U5GIECI^?LEI!`2,$QH`2/<]37F?@O7_[)U+[/.^+2Y(#9Z(W9OZ'_`.M7
MJU)E(*R]0\.Z3JLXGO;,22@8W;V4X_`BM2BD,Y:^\$^'UM99?*DMEC0LSI*3
M@`9S\V:\KKT#Q]KX"?V/;L"3AK@@].X7^OY5Q6FZ=/JM_%9VRYDD.,GHH[D^
MPIHEEK0M`N]>NS%!\D:<R3,/E3_$^U=]:_#_`$:``S^?<GOO?:/_`!W'\ZV]
M(TFVT;3X[2W4<#+OCEV[DU?HN.Q2LM'T[3B&M+*"%\8WJ@W8]-W6KM%%(844
M44`%%%%`!1110`4444`%%%%`&1XI_P"17U#_`*Y'^=>,U[-XI_Y%?4/^N1_G
M7C--$L****8CT;X;?\@^^_ZZK_*NWKB_AO&PTJ\D/W6G"CZA1G^8KM*EE(**
M**!A1110`4444`8/C.W%QX5O.FZ,+("3TPPS^F:\@KVOQ`BR>'=25AD"VD;\
M0I(_45XI31+"BBBF([7X;W)35+RVSQ)"'_%3C_V8UZ17DW@641^*K=2,^8CJ
M/;Y2?Z5ZS292"BBBD,S==TB+6]*ELY,!C\T;G^%QT/\`3\:\8G@EMKB2"9"D
ML;%74]B*]YKAO'OA_P`Z/^V+9,R(`+A0.J]F_#H?;'I30FCSNE1VC=71BK*<
MA@<$'UI**9)[#X6UY==TL.YQ=0X6=??LWT./YUN5XOX>UE]#U:.Z`W1'Y)5]
M5/7\1UKV6&:.X@2:%P\;J&5AT(-2RD/HHJ.>>*VMY)YG"11J6=CV`H&97B;7
M%T/2FE!!N9,I"I&?F]?H*\QT#1Y=>U=8"6\O.^:0\X7OSZFEUW5Y_$.L&54;
M:2(X(NX&>/Q->F^&=#70]*6(@&YDP\S`Y^;T^@IBW-:&&.W@2&%`D:*%51T`
M%/HHI#"BBB@`HHHH`Y#XC?\`(O6__7TO_H#UP.C:3+K5\;2&14D\MG7=T)';
MVKOOB-_R+UO_`-?2_P#H#UR7@AV3Q;:*IP'$BM[C83_,"F2]S#N;::TN)+>X
MC:.6,X96Z@U%7L/B+PU;:];$X6*\4?NYL?HWJ/Y5Y/?Z?=:9=M:WD1BE7G![
MCU![B@&BM6EHNM76AWPN+<Y4\21D_*X]#_0UFT4Q'M^E:K:ZS8K=6KY4\,I^
M\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*3
M+U%%%`PHHHH`\$D1HI&C<8925(]"*]KT+_D7M-_Z]8O_`$`5X[JD9AU:]B8@
MLD[J<=,AC7L.@L&\.Z:5((^RQC@]PHILE&C1112*"BBB@`HHHH`CGFCMK>6>
M4XCB0NQ]`!DUX=?7<E_?3W<OWYG+D>F>U>E>/M2^QZ$MJIQ)=OM_X".3_0?C
M7G.E6#ZGJEM9)G,KA21V'4G\!DTT)E1E*G#`@X!Y'8TE=M\0-'6UGMM0@C5(
MG40N%'1E'R_^.C'_``&N)IB'Q2R03)-$Q22-@RL.H(Y!KV[2K]=3TNVO4QB5
M`2!V/0C\#FO#J[_X=:IQ<:7(W_3:+)^@8?R/YTF".^HHHI%!1110!!>6L=]9
M3VLH_=S(4/MD=:\0O;22PO9K2;_61.4..^.]>[5YQ\1-+,-]#J2+\DX\N0C^
M^.F?J/\`T&FA,XFI()I+:XBGB.V2)PZGT(.14=%,D]TT^]CU'3[>\B^Y,@<#
M.<>H_#I5FN'^'>J&6UGTN1LM%^]B'^R3R/S.?^!5W%26%%%%`%>^NEL;"XNG
M(VPQL_/?`Z5X9)(\TKRR-N=V+,?4GK7IGQ!U(6VCQV*-^\NF^8?["\_SQ^M<
M;X2TW^T_$5O&PS'%^^D^B_\`U\"FA,],\.:9_9.A6UJ1B7;OE_WSR?RZ?A6K
M112&%%%%`!11574;V/3M.N+R3[L*%L>I[#\3@4`>:>.]2^VZ^;=&)BM%\L#M
MN/+'^0_"N7P<9QQZT^662>9YI6+R2,69CU)/)-=]/X8_XM]$JQ@WD8^U\#DY
MY(_[YP/JHID[GGU%%%,1Z?\`#_5!=:,UB[9EM6X![H>1^N1^5==7COA35?[)
MUZ"5SB&7]U+[`]_P.#7L5)E(****0PHHHH`****`"H+RTAO[.6UN%W12KM85
M/10!XGK>DRZ+JDMG(2P7YHW(QO4]#_3Z@UG5ZSXQ\/G6M-$L"YO+?+1C^^.Z
M_P!1[_6O)B""01@CJ*9+"O2O`_B/[;;C2[I_](B7]RQ_C0=OJ/U'TKS6I;:X
MEM+F.X@<I+&P96'8B@#WBLCQ'KD>A:6TYPT[_+#&3]YO7Z#K_P#KI-)\0VFH
M:%_:4LB0B,8N`>B,.OY]OJ.]>8^(]<DUW5&G.5@3Y88R?NKZ_4]?_P!5`VS-
M=YKRZ9W+RSRODGJ68FO6/"GAU=#L-TRJ;V89E8<[1V4'^?O6)X&\->6BZO>1
M_.PS;HPZ#^_^/;\_2N[H8)!1112&%%%%`!1110`4444`%%%%`!1110`4444`
M9'BG_D5]0_ZY'^=>,U[-XI_Y%?4/^N1_G7C--$L****8CT[X<_\`(O7'_7TW
M_H"5U]<?\.74Z#<H#\PN22/8JN/Y&NPJ2T%%%%`!1110`4444`9^N_\`(O:E
M_P!>LO\`Z`:\2KV?Q/-Y'AG47W`9A*9/^UQ_6O&*:)84444Q'0>"03XNLL#I
MYF?^^&KUVO+/A]&7\2E@1B.!V.?3(']:]3I,I!1112&%(Z+(C(ZAD8892,@C
MTI:*`/&_$VAOH>JM$`3;29>%B<_+Z'W%8U>S^(=%CUS2GMC@3+\T3_W6_P`#
MTKQN:&2WG>&9"DB,593U!%-$L97H/P_UW<K:/._*Y>W)/4=2O\S^=>?5)!/+
M;7$<\+E)8V#(P[$4P/>:\U\<^(OMEP=+M7S;Q-^]8'[[CM]!_/Z5?U3QRDGA
MN(VC;-0G!1PO_+''4_CV_P#K5S7A70#KFIA9`PM(OFF8=_1?Q_QI#;.A\!^'
M>FL72^UNI_5C_3\?:N_I$18T5$4*BC"J!@`>E+2&%%%%`!1110`4444`<M\0
M$5_#.YADI.C+['D?R)KBO!7_`"-UC_VT_P#1;5V_C[_D6'_ZZI_.N(\%?\C=
M8_\`;3_T6U,3W/7JR=>T"UUZS\J;Y)5YBF`R4/\`4>U:U%(9XAJNE76CWS6M
MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HKR+5=*NM'OFM;I,,.58?
M=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/;]*U6UUFQ6ZM7RIX93]
MY#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK-BMU:OE3PRG[R'T-24F
M7J***!GB6N_\C#J7_7U+_P"AFO5?"C!O"^GE2"/*QP>X)KRWQ#&8O$>I*Q&3
M<.W'H23_`%KTOP5_R*-C_P!M/_1C4V2C?HHHI%!1110`4451UC4!I>D75Z1D
MQ)E1ZL>!^I%`'F?C;4O[0\12QJ?W=M^Y7ZC[WZY'X5K?#G3?,NKG4G7Y8QY4
M9/\`>/)_3'YUP[,68LQ)8G))/)->S>&]-_LK0;6V9<2[=\GKN/)S].GX4R42
M:]IO]K:)=68`,CIF//9QR/IR,?C7BA!!((P1U%>^UY%XSTW^SO$4Y12(;C]\
MGX_>_7/Z4(;.?JYI5^^EZK;7J=8GR1ZCH1^()JG13)/>XI$FB26-MR.H93Z@
M]*=7+>`]3^W:"+9VS+:-L_X">5_J/PKJ:DL****`"LOQ%I@U?0[FU'^LV[XS
MCHXY'Y]/QK4HH`\"(()!&".HHKH/&6E?V9K\I10(;C]ZF.V>H_//Z5S]407]
M%U)])U>WO$/"-\X_O*>"/RKVR.1)8UD1@R,`RL.A!KP2O4O`>J_;M%-I(?WM
MH=@]T/W?ZC\!292.KHHK/UO41I6C75X3AHT.SC/S'A?U(I#/,?&.HG4?$=QA
MLQ0?N4Q[=?US76_#W3?L^DRWSKA[E\+D?P+_`(G/Y"O.;6WDO;V&WCYDFD"#
M/J3BO<;.UCLK.&UA&(XD"+^`IL2)J***0PHHHH`*XCXBZEY5E;Z<A^:9O,D_
MW1T'XG_T&NWKQGQ/J7]J>(+J=3F)6\N/_=7C/X\G\::$QGAS3O[5UZUMB`8]
M^^3(XVKR1^.,?C7M)`(((R#U!KA?ASIVRWNM2<#,A\F/CD`<G\SC\J[JA@CQ
M7Q!IO]DZY<V@'[L-NC_W3R/\/PK,KT3XC:;YEK;:DB_-&?*D(_NGD?KG\Z\[
MH$PKV/PIJ?\`:OAZWE8YEC'DR?[R]_Q&#^->.5V'P]U/[-JTM@[?)=+E?]]>
M?U&?R%#!'IM%%%(H****`"BBB@`HHHH`*\V\=>'OLEQ_:MJF()3B90,!']?H
M?Y_6O2:CG@BN;>2"9`\4BE74]P:`/!J*U_$FB2:%JKP?,;=_GA<]U]/J.GZ]
MZR*H@>LTJ121+(RQR8WJ#PV.F:Z3P?X;.L7GVFY7_086^8$?ZQO[H]O7_P"O
M7,5V/@;Q#]BNAIET_P#H\S?NB3]QSV^A_G2&CTP````8`Z`4444B@HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`R/%/\`R*^H?]<C_.O&:]F\4_\`(KZA
M_P!<C_.O&::)84444Q'HWPV_Y!]]_P!=5_E7;UQ_PY4#0+AL#<;I@3CG&U?\
M3785+*04444#"BBB@`HHHH`Y?Q]<^1X9:+O/*B?E\W_LM>55V_Q'OA)?6EBI
M_P!4AD?ZMP/T'ZUQ%-$L****8CO_`(;6AVW]X<[25B7TSU/\UKOJR/#.FG2M
M`MK=UVRE?,E!Z[FYP?IP/PK7J2T%%%%`!1110`5Q/CSP\MQ;'5[9`)HA^_`_
MC7IGZC^7TKMJ;)&DL;1NH9&!5E/0@T`>"45)<1"&YEB!R$<J#ZX-1U1`5[/X
M<TR'2]$MX8@-SH))&_O,1R?Z5XQ7NMA_R#[;_KDO\A28T6****104444`%%%
M%`!1110!RWQ`=4\,[6."\Z*ON>3_`"!K@O"W_(SZ?_UU'\J[?XC?\B];_P#7
MTO\`Z`]<1X6_Y&?3_P#KJ/Y4T2]SV:BBBD4%9NM:+:ZY8FWN!AAS'*!\R'U'
M]16E10!XAJNE76CWS6MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HK
MR+5=*NM'OFM;I,,.58?=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/
M;]*U6UUFQ6ZM7RIX93]Y#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK
M-BMU:OE3PRG[R'T-24F>5>+HS%XJOU8@DN&X]"H/]:]"\$.K^$[15.2AD5O8
M[R?Y$5P7C7_D;K[_`+9_^BUKM_`/_(L)_P!=7_G3!;G3T444AA1110`5P7Q&
MU+"6NFHW4^=(!^2C^?Y"N])`!).`.I->*:_J)U77+J[SE&?$?^X.!^@S^--"
M97TV6V@U*VFO%=[>.0,ZH`2P'.,&O2D\?Z(R@DW"D_PF+D?D:\\M=!U6^MUN
M+:QFEA;.UU'!QQ4W_"+:Y_T#)_R%`CO_`/A/M#_YZ3_]^C7->,==TG7+2W:U
M>3[3"YQNC(!4]?Y"L7_A%M<_Z!D_Y"C_`(1;7/\`H&3_`)"@-3(HJ2>"6VG>
M">-HY4.UE88(-1TQ'2^!]2-AXACB8XBNAY39/?JI^N>/QKUBO`T=HW5U.&4Y
M!]#7MNC:BNK:1;7J]9$^8>C#@C\P:3*1?HHHI#"BBB@#FO&^E?VCH331INGM
M3YBXZ[?XA^7/X5Y/7OC*'4JP!4C!!'!%>+>(-+.D:U<6@!$8;=$3W0\C_#\*
M:$S,K;\*:K_9.O02N<0R_NI?8'O^!P:Q**9)[[7!_$?4=L5KIJ$Y8^<_/;D*
M/SS^0K?\)ZL-4\/PR2-F6']U*6]0.OXC!_.O,O$&I?VMKES=@_NRVV/_`'1P
M/\?QI(IF[\/M-^TZO)?.I,=LGRGMO;C\>,_I7IM87A#3?[-\.VZLN)9AYTGX
M]!^6*W:0(****!A1110!C^*=2_LOP_<S*P65QY47^\W''T&3^%>-5VWQ$U+S
M;^#3D8%8%\R0#^\>@/X<_P#`JY2QTR]U)G6SMGF*`%M@Z4T2SN]%\9Z)I^E6
M]EMN8_)C"DF(89NI(P3WR?QK0_X3[0_^>D__`'Z-<!_PBVN?]`R?\A1_PBVN
M?]`R?\A0%V=EJ_B_0=3TFZLR\V98R%S%T;J#^>*\VK7_`.$6US_H&3_D*IWV
MF7NFLBWEL\)<$KO'6@"I4UI=265Y#=0G$D3AU_`U#13$>[VES'>6<-S$<QRH
M'7Z$9J:N.^'NJ?:=*DL';]Y;-E/]QN?YY_,5V-26%%%%`!1110`4444`%%%9
M/B'7(M"TUKAL-,WRPQG^)O\``=__`*]`'-_$/4;,VT6G[%DNPPD#`_ZH?_7]
M/Q]*\\JTQN]6U'/SSW5P_P"+$_Y_"NPUKP,+30(I[0F2\@7,X!SY@[X^G\O>
MF3N<+1113$>K^#?$/]L6'V>X;-Y;@!B?XUZ!OKZ__7KIJ\,TW4)]+U"&\MSB
M2)LX/1AW!]B*]ITW4(-4T^&\MSF.5<X/53W!]P:3*3+5%%%(84444`%%%%`!
M1110`4444`%%%%`!1110!D>*?^17U#_KD?YUXS7LGBQU3PMJ!8X'EX_$D`5X
MW31+"BBBF(]+^'$H.C746.5N-V?JH']*[*O,?A]J26NL2V<AP+M`%/\`M+D@
M?D37IU2RD%%%%`PHHHH`*CN)X[6VDN)FVQQJ78^@%2$@`DG`'4FO-O&?BI+_
M`/XEVGR[K8<RR+T<^@]J`.7U6_?5-5N;U^LKY`]!T`_``53HHJB`KI?!>BG5
M-96>1<VUJ1(^?XF_A'YC/T%8NF:=<:K?Q6ELFYW/)[*.['V%>R:1I<&C:;%9
MP<A>68]78]328TB]1112*"BBB@`HHHH`****`/"K[_D(7/\`UU;^9JO5B^_Y
M"%S_`-=6_F:KU1`5[XB+&BHHPJC`'H*\#KWVDRD%%%%(84444`%%%%`!1110
M!R'Q&_Y%ZW_Z^E_]`>N(\+D#Q/I^3C]\*[?XC?\`(O6__7TO_H#UP.A?\C#I
MO_7U%_Z&*:)>Y[;1112*"BBB@`K-UK1;77+$V]P,,.8Y0/F0^H_J*TJ*`/$-
M5TJZT>^:UNDPPY5A]UQZBJ->UZUHMKKEB;>X&&',<H'S(?4?U%>1:KI5UH]\
MUK=)AARK#[KCU%,EHHUI:+K5UH=\+BW.5/$D9/RN/0_T-9M%,1K^)KZWU/6Y
M+ZV9BDZ(Q5A@J0H!'Z5WGP_D5_#6T=4G=3]>#_45Y97IWPY_Y%ZX_P"OIO\`
MT!*3&CKZ***104444`8/C'4O[-\.SE6*S3_N8\>_7],_I7DD$,ES<101#=)*
MX11ZDG`KK/B#J7VG5X[%&)CMD^8=M[<_CQC]:A\`Z=]LU[[2P/EVB;^G!8\`
M?S/X4R7N>EV-I'86$%I%]R%`@/KCO5BBBD4%%%%`'FWQ#TSR-2AU%!\EPNQ_
M]]>GYC'_`'R:XNO9O$^F?VMH%S;JFZ91YD7'.X=A]1D?C7C--$L*[WX<ZGA[
MG3';@_OHOKT8?R_(UP57]&U`Z7K%K>`G;&XW@=U/!'Y9I@CVZBD5@ZAE(*D9
M!!X(I:DH****`"N,^(6E?:-.BU*,?O+<[']T)_H?YFNSJ*YMX[NUEMY1F.5"
MC#V(Q0!X/15G4+*33=0GLY>7A<J2._H?Q'-5JH@T],UJXTRRU"VB^[>1;"?[
MISU_(L/Q'I2^'=,_M;7;:U(S'NWR_P"X.3^?3\:RZ]$^'.F^7:W.I.OS2'RH
MR?[HY/ZX_*D-'<T444B@HHHH`*9-,EO!)-(VV.-2['T`&33ZY;QYJ7V+0?LR
M-B2[;9[[1RW]!^-`'FFHWCZAJ-Q>2?>FD+X]!V'X#BO3/`FF_8M`%PZ@2W;>
M83WVCA1_,_C7F>GVCW^HV]HG#32!,^F3UKW&&%+>".&-=L<:A%'H`,"FQ(?1
M112&%<SXYTS[?X?>95S+:GS1C^[_`!?IS^%=-2.BR(R,,JPP1ZB@#P.BKVLZ
M>VE:O<V;=(W.T^JGD'\L51JB#9\+:G_97B"WF9L1.?*D_P!UO\#@_A7LE>!5
M[/X9U+^U=`M;AF+2A?+E)Z[AP3^/7\:3*1K4444AA1110`444$@`DG`'4F@"
M"\O(+"TENKF01PQC+,:\<UW6I]<U)[J7Y4'RQ1YR$7_'UK5\8^)?[8NA:VK'
M[%">#_ST;^]]/2CP?X:.L7?VJY3_`$&%N0?^6C?W?IZTR7J=#X%\._8[<:I=
M)B>4?N5/5$/?ZG^7UKM*````!@#H!12*/+?&GAS^RKO[;;)BSG;D#_EF_I]#
MR?TKE*]WN[2&^M);6X3?#*NUEKQG6](GT34I+2;E>L;XX=>QIHEHSJZ?P9K_
M`/9.H_9IWQ:7!`;/\#=F_H?_`*U<Q13`]]HKD/`VO_;[+^SKA\W-NOR$_P`<
M?^(Z?3'O77U)04444`%%%%`!1110`4444`%%%%`!4<]Q!:Q&2XFCBC'\4C!1
M^9KS'Q1XCU=-;O+2*^EB@BDVHL7R$#CN.?UKEY9I9WWS2O(W]YV)/ZT["N=M
MXS\56M_:?V;I\AD0L&EE&0IQ_"/7G!KAJ**8@HHHH$*CM&ZNC%64Y#`X(/K7
MH.@^/XV1;?6!M<8`N$&0?]X=C[C\A7GM%`SW6UOK2^0/:W,4RXS^[<''U]*L
M5X%5C[=>?\_4_P#W\-*P[GNC,$4LQ`4#))/`%8NI^+-(TL$/=+-+CB*#YS^)
MZ#\37D$LTLQ!EE>0CH68G%,HL%SH]=\8W^LJT$?^BVIX,:'EQ_M'O].E<Y14
MUK:7-[,(;6"2:0_PHI)IB(:T-(T6]UJZ$%I'D#[\AX5!ZD_TZUU&C?#Z>4K-
MJTGE1]?)C.6/U/0?K^%=]:6=M86ZV]K"D42]%44KA8HZ%H%IH-H8H/GE?F29
MA\S_`.`]JU:**104444`%%%%`!1110`45Q=U\1[&/(M;*>8CNY"`_P`_Y5BW
M7Q$U27(MX+>`'O@LP_/C]*+"N<Q??\A"Y_ZZM_,U7ITCM+(TCG+,2Q/J33:H
MD*]]KP*NRLOB'>6T$44UE!*(U"Y5BI(`Q[\TF-'I=%<1;?$BTD=1<V$L()P6
M1P^!Z]!7;TB@HHHH`****`"BL;Q!XBM_#\4#31/*TS$*JD#@=3^HK!_X639_
M]`^?_OL4!<F^(\BC0[6/^)KD,/H%;/\`,5YW8R>5J%M)OV;)5;=G&,$<YK9\
M3^*&\0&&-+?R((22`6W%B>Y]/I7/4R6>^T5YO9_$:[AA2.YL8YRJ[2RR%2Q]
M3D&M!/B3:D+YFG3*>X60''\J5AW.XHJ&TN4O+."ZC#!)HUD4-U`(R,_G4U`P
MHHHH`*S=:T6UURQ-O<###F.4#YD/J/ZBM*B@#Q#5=*NM'OFM;I,,.58?=<>H
MJC7M>M:+:ZY8FWN!AAS'*!\R'U']17D6JZ5=:/?-:W288<JP^ZX]13):*->G
M?#G_`)%ZX_Z^F_\`0$KS&O3OAS_R+UQ_U]-_Z`E#!'7T45#=W*6=G/=2!BD,
M;2,%ZD`9./RI%$U5[Z\BT^QFNYCB.)"Q]_:N&NOB3(<BTTY5]&EDS^@`_G7-
M:QXEU+7%$=U(BPJ=PBC7"Y]?4_B:=A7,Z[N9+R\FN93F25R[?4G->G>`;-;?
MPXMP`-]S(S$]\`[0/T/YUY76UH_BG4]$C\FVD1X,D^5*NY0?;H1^=`D>QT5Y
M]!\2I!@7&FHW(R8Y2,#OP0?YUZ#2*"BBLC7]?@\/VT4LT,DOFMM4)@?GF@#7
MKQSQ7IG]E>(;B)1B*0^='_NMV_`Y'X5M7?Q'OI!BTLX(,]W8R'^@_2N5U#4;
MK5+IKF\E,DI&,D8P/0`4T2V5:***8CU7P+JPO]$%J[?OK3"')ZI_"?Z?A745
MX;IVIWFDW/VBRF,4F,'@$$>A!X-=1;?$?44(^TV=M*H'.S*$_CDC]*5BDSTJ
MBJNFWRZEIT%XB%%F7<%)Y%6J0PHHHH`\Z^(NF^7=V^I(IVRCRI#VW#I^8S_W
MS7#U[1XCTT:KH-U;`9DV[X\#)WCD?GT_&O%Z:)8^&%[B>.&-=TDC!%`[DG`K
MW#3K&+3-.@LH?N0H%SZGN?Q.3^->9>!=/^V^(TE89CME,ISZ]!^IS^%>KT,:
M"BBBD,***X_6O'D>F7T]G#8O+)$=I9W"C/X`Y_2@#L*\E\:ZHNI>('6)@T-L
MOE*0>">I/YG'X5)J'CK5[Z)XHS%;1L,'RE.['U/],5S%-$MG8?#NT2;6YKEL
M$P1?*/=N,_EG\Z]-KP[3=4O-(NOM%E+Y;XP>`0P]"#756_Q(O4"BXL8)<==C
M%,_GFAC3/1Z*S="U==;TQ+U83%EBI0MG!'O6E2&%%5[Z\BT^QFNYMWEPH68*
M,D^PKAKKXDR'(M-.5?1I9,_H`/YT!<7XCZ:`;74D`!8^3)[GDK_[-^E<%6KK
M'B/4M;"K=RKY2MN6)%PH/\S^)K*IDL*[+X?:L+74I-.E;$=R,QY/1QV_$?R%
M<;2H[1NKHQ5E.0P."#ZTP/?**\MM/B!K$"JLRV]P!U+H0Q_$$#]*[7PUXD7Q
M%#.?LY@D@*[EW;@<YP0<#T-2.YNT45Q4WQ(L%SY%C<OQQO*KS^&:!G:UY[XU
M\5>89=(L6^0?+/*#][_9'MZ_E]<_5?'NHW\+0VT:6<;`@E#N?'^]V_`5RE.P
MFR>RM)+^]AM(?]9*X09[9[U[=864.G6,-I`N(XEVCW]3]2>:\+1VC=71BK*<
MA@<$'UKK-.^(&J6H5+N..[0#&6^1_P`QQ^E#$CU"BL30O%%EKSO%`DD<R+N9
M)`.G3((//6MND4%8'BS0EUK26,:9NX`7B(')]5_'^>*IZGX]L+"YGMH[:>:>
M%V1NBKD9!YZ]1Z5@7?Q&U"566UM((,]&8ER/Y#]*8KG&44K,68L3DDY-)3))
M[.[FL+R*ZMVVRQ-N4U[)H>LV^N:<ES"<..)8^Z-W'T]#7BE7M+U>]T>X,]E,
M48C#*>58>XI#3/;Z*\_L_B2V`+[3P3W>!\?^.G_&NXL;R+4+&&[AW>7,@90P
MP1[&D5<L4444`%%%%`!1110`4444`<S?^!M,U&_FO)I[M9)6W,$=0`?;*U77
MX=:.&!,]ZP!Z&1<'_P`=KKJ*`L<TG@/0D<,T$K@?PM*<'\L5-_PA7A[_`*!_
M_D:3_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*H_X0KP]_P!`_P#\C2?_`!5;]%`&
M!_PA7A[_`*!__D:3_P"*I#X)\/$$?8,>XFD_^*KH**`.8_X0'0_^><__`']-
M0O\`#O1G<LLUX@/\*R+@?FIKK:*`L<A_PKG2/^?F^_[[3_XFGQ_#S1D;+27<
M@QT:08_117644!8P[;P?H5L05L$D8=Y6+Y_`G'Z5L0P0VT8C@B2)!T5%"C\A
M4E%`!1110`4444`%%%%`!1110`4C*'4JP!4C!!'!%+10!R'_``KG2/\`GYOO
M^^T_^)J6/X?:*BX8W4ASU:09_0"NJHH"QS'_``@.A_\`/.?_`+^FIQX)\/``
M?8,^YFD_^*KH**`L<T_@/0G<LL$J`_PK*<#\\U3D^'&EE?W=W>*WJQ5A^6T5
MV-%`6.,A^'=I#/'*+^8E&#`;!S@UV=%%`!1110`4444`87B7PVOB**W7[3Y#
M0LQ#>7OR#CCJ/05A1_#6`+^]U*1FSU6(*,?F:[JB@+''I\.=*"`/=7I;N0R@
M?EMI?^%<Z1_S\WW_`'VG_P`377T4"L<2_P`-[(EO+O[A1V#*IQ_*J_\`PK/_
M`*B__DM_]G7?447"Q7L;;[%I]M:;]_D1+'NQC=M`&<?A5BBB@84444`%%%%`
M!65K^A6^O6'D2G9*F6BD'\!_J/:M6B@#R-_!'B!7918A@#@,)DP??DYKN?!>
MEWFDZ/-!?0^5*UPSA=P;C:HSP3Z&NCHHN*P5#=VR7EG/:R%@DT;1L5Z@$8./
MSJ:B@9R'_"N=(_Y^;[_OM/\`XFKL'@?086W&U>4Y!'F2M@?@"/UKHJ*`L83^
M#?#\CEFTY03_`'9'4?D#4,O@;0)``MH\>.Z3-S^9-='10%CF/^$!T/\`YYS_
M`/?TUT]%%`!65K>@6NO0Q174DR+$Q9?*(!S^(-:M%`'+CP#H8`&R<^_FU+%X
M%T"/.ZUDDS_?F;C\B*Z.B@+&!_PA7A[_`*!__D:3_P"*I&\$^'RI`L"I(ZB9
M\C_QZN@HH`Y9_A_HCH547*$_Q+)R/S!J'_A7.D?\_-]_WVG_`,377T4!8J:9
MI\.E:?#96Y<Q1`X+G).22<_B:MT44`%%%%`!7`ZA\/9KG4;B>"\BCBED+JC*
M25R<XKOJ*`,'POX=_P"$?M9U>999IG!9E&``!P/U/YUO444`%%%%`!7,7_@;
M3-1OIKR:XO!),Q9@KJ`/I\M=/10!R\/@#0XL;UN)L'^.7&?^^0*N-X.T!D5#
MIR87IB1P?Q.<FMRB@+'/MX)\/E2!8%21U$SY'_CU0?\`"`Z'_P`\Y_\`OZ:Z
M>B@+%/3-,MM)LEM+166($M\S9.35RBB@"M?V4>HV$UG,SK'*NUBA`('MFN>C
M^'^B(N&^TR'^\TG/Z`5U5%`',IX#T)6!,,S`?PF4X/Y5/_PA7A[_`*!__D:3
M_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*J!_`>A,Q(AF4'^$2G`_.NFHH"QR)^'6
MCDD_:+T>V]/_`(FM?0_#EGX?\_[))._G[=WFL#C;G&,`>IK7HH`*XC_A6UG_
M`-!"?_O@5V]%`'')\.-+"`275XS=RK*!^6TU/'\/M%1<,;J0YZM(,_H!7544
M"L<L_P`/]$="JBY0G^)9.1^8-5I/AQIA7]U=W:MGJQ5AC\A7944#L<[H'A*W
MT&]DNHKF65GC,>&```)!_I71444`<M=^`M+O+R>ZDN+P/-(TC!77`).3CY?>
MH?\`A7.D?\_-]_WVG_Q-=?10%CEQX!T,`#9.??S:L#P3X>``^P9]S-)_\570
M44!8YB3P#H;[ML<Z9SC;*?E^F<_K55_AQI90B.ZO%;L692/RVBNQHH"QQ'_"
MMK/_`*"$_P#WP*["RM5L;"WM$.Y88UC!(QG`QFIZ*`"BBB@`HHHH`****`"B
MBLCQ1KG_``C?AVZU;[/]H^S[/W6_9NW.J]<''WL]*<8N345NQ2DHIR>R->BO
M(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNNOZAB/Y?Q7^9R_7L/_-^#_R/
M7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_
M`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`
M-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P
M_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U
M[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8
M?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q
M7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/
MY?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&
M(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^
MH8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]
MKH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O
M_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y
M._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O
M_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_
MU+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>
M'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC
M_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_
M`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_
M`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`
MD[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_
M`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_
M^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A
M_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_
MX7A_U+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR
M+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\
MB_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7
M:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_
M`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-
M^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S
M?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/
M_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?
M7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7
M^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_
M%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^
M7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H
M8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O_P!K
MH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`
MVNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_
M`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_
M`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N
M_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'
M_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A
M_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z
M/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]
MKH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O
M_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_
M`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2
M[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_
MU+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>
M'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7
MA_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B
M_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CU
MVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R
M/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\
MCUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#
M_P`CUVBO(O\`A>'_`%+O_D[_`/:Z],T#5?[<T*SU/R?(^TQ[_+W;MOMG`S^5
M95<-5I*\U8UI8BG5=H.YHT445@;!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`>?
M?$3QUJGA*_LH+""SD2>(NQG1B00<<885QG_"Z/$?_/EI7_?J3_XNK?QL_P"0
MSI?_`%[M_P"A54^%?A?1O$G]K?VM9_:/L_D^5^]=-N[?G[I&?NCK7LTJ=".&
M56<;_P##GCU:E:6)=*$K?\,7;'XV7ZNHU#2;:5,_,;=V0X]@=W^?2O4/#WB7
M3/$]A]KTV8N%P)(W&'C)'1A_49'H:\U^('PTL=,TB35]"CDB6#!GMBY==G=E
M)R<COD]/3'/%>!_$4OAOQ/;7`<"VE80W(8X7RR>3]1U_"IEAJ->DYT59HJ.(
MK4*BA6=T?2U%%%>0>L>3^+OB-XG\+^([C3FLM,:$'S+=VBD)>,_=)^<<]0>.
MH-=#\/?'3^+8KJ"^2WAOX#O"0@@/&>,@$D\'@_45%\4_#*ZUX<:_@CS>Z>#(
M".K1_P`:_P!?P/K7B_AK7)?#OB"TU.+)$3_O$'\:'AE_+./?!KUZ5"EB,/[J
MM)?G_P`$\JI6J4,1[SO%_P!?@?0_B_Q$GA?PY<:B0C3#$=O&_1Y#T!]AR3[`
MUP_@[XA>)_%7B&&P%IIB6Z_O+B18I,K&#SCY^IS@?6N6^*'BN+Q#K4-K8SB7
M3[1/E=3Q([`%F_`8'X'UKT?X8>&/[!\-K=3KB]OPLK@CE$_@7\CD^YQVK)T8
M4<-S37O/8T56=;$<L'[J.WHHHKS3T3Q*]^,/B&VO[B!+/3"L4K("8I,X!(_O
MUWO@#QH?%VFS&Z6&+4('Q)'%D`H>C`$D^H//;WKP#5?^0Q??]?$G_H1K1\)>
M(9?#/B*VU!"?*SY<Z#^.,D;A^@(]P*]ZM@J<J7N*S/"I8RI&K[[NCW+X@^)[
MWPIH,%_816\DLETL)$ZL5VE7/8CGY14'P[\6W_BVPO9[^&VC:"5440*P!!&>
M<L:R?C#/%<^!]/G@D62*6]C='4Y#*8Y""/;%5_@G_P`@?5?^OA/_`$&N!4H?
M5'.VMSN=67UM0OI8]1HHHK@.\1W6-&=V"HHRS$X`'K7A\_QHUW[1)Y%CIPAW
M'RQ)&Y;;GC.'QG%>B_$G5_['\$7K(Q66ZQ:QD>K_`'O_`!T-7SO':3S6L]S'
M&3#!M$CY'R[C@?G@UZN7X>$XN=17/+Q^(G"2A!GT#\._&5SXNL+U[Z*WCN;:
M51M@4A=C#C@D\Y#5V=?/WPGU4Z?XUBMF($5[&T+9[$#<I^N5Q^-?0-<N-HJE
M5:CLSIP=5U:5WN@KF_'.MZCX=\-2:IIL5O(\,B"43J2-C';Q@@YW%?UKI*HZ
MSIR:OHM[I[XQ<PM'DG&"1P?P.#7/3:4TY;'143<&H[GEGA[XN:MJ'B&PLM0M
M-/2UN)EB=HD=6!;@')8CJ1VZ5[#7R21+;7!!W1RQ-C@X*L#_`#S7U/HNHKJ^
MAV.HJ`/M,"2$#H"1R/P.17?F&'A3Y905DSAP%>53FC-W9P?C[XD7_AG7TTW3
M8+.4+"KS-.KL58DX'##M@]^M=7X+UC4=?\,P:GJ4,,4L[,46%64;`<`X))YP
M3],5\_Z_>R>(_%]Y<1?.UW=;(1DG*YVH/RQ7TMIEC'IFEVEA$<I;0I$IQC(4
M`9_2EBZ4*5&$;>\QX6K.K5E*_NHM4445YQZ!P_Q$\;W7A&.P2PBMY;FY+EA.
M"P5%QV#`Y)/'T-<59?&76WO[9+NTTU;9I5$S)&X8)D;L$N><9K#^)VK_`-K>
M-[M58F*SQ:H/0K][_P`>+?I7*7=I/8W3VUS&8YH^&0D''&>U>]A\'2]DN=:L
M\/$8NI[5\CT1]:45S?@+53K'@K3;ER#*D?DR?5#MR?<@`_C725X<XN$G%]#V
MH24XJ2ZA7GWQ`\8^(?"-[;O:6EC+I]PN%DEC<LKCJI(8#IR/Q]*]!K(\3Z#!
MXDT"YTV;`9US$Y_@D'W6_/K[9K2A*$:B<U=$5HRE!J#LSAO!'Q0O-?\`$"Z9
MJT%G")D/D/`K+EQS@[F/49_'`[UU_C3Q.GA7P_+>@1O=,0EO$_1W/J!S@#D_
M_7KYQD2\T;5F0[H+RSFZCJCJ>H_$5L^,/%]UXNO+6:=!%';PA%C'3>0-[?B?
MT`KU9X",JL91^'K_`%YGE0QTHTI1E\73^O(]`\'_`!#\3^*?$,%@++35MQ^\
MN)%B?*1CKC+]3P!UY/I7JU<=\./"O_"-^'5>XCVZA>8EFW+AD&/E3\/YDUV-
M>9BI4W4:IJR1Z6&C-4TZCNV%%%%<YT!1110!D^)M4GT7PU?ZE;+&TUO%O19`
M2I.>^"#^M>0_\+H\1_\`/EI7_?J3_P"+KVG4].M]7TVXT^Z#&"==CA3@X^M<
M!KWPO\-:?X>U.]@BN1-;VDLL9,Q(W*A(X^HKNPDZ"7+55VV<6*A7;YJ;LK'*
M_P#"Z/$?_/EI7_?J3_XNC_A='B/_`)\M*_[]2?\`Q=<#80I<:C;0R9V22JC8
M]"0*]X_X5'X5_P">5U_W_-=]>.%H64X[G#0EBJU^66QW5%%%>$>V>7^.?B/K
M'AGQ*^FV5M8R0K$CAID<MDCV8#]*YO\`X71XC_Y\M*_[]2?_`!=4_BY_R/<O
M_7O'_*MWX8^#=`\0^&[B[U6P^T3I>-$K>=(F%"(<85@.I->TJ>'IX>-2<;['
MC.=>I7E3A*VYG?\`"Z/$?_/EI7_?J3_XNO0?AWXMO_%MA>SW\-M&T$JHH@5@
M"",\Y8U+_P`*P\'?]`?_`,F9O_BZVM$\.:3X<AEATJU^SI*P9QYC/DCC^(FN
M2O6PTH-4XV?]>9UT*6(C-.I*Z_KR-2BBL'QGK3:!X2O]0C8"=4V0^N]B%!'K
MC.?PKBA%RDHKJ=DI*,7)]#G_`!A\3['P[<R:?8PB]OTX?YL1Q'T)')(]!^>:
MX"7XO^*))"RFRB!_@2#@?F2?UKB((9[^^CACW2W%Q($7/)9F.!^))KZ!L?AA
MX9M](2SN;`7,VT>9<,[!V;N001@>P_7G/L3IX;"Q2FKMGDPJ8C%2;@[)'.^&
MOC"EY>1VNNVL-L)#M%U"2$4]MRG)`]\UZH"&4,I!!Y!'>OESQ-HQ\/\`B2^T
MO<66"3",V,E"`RDX[X(KW/X8ZN^K>"+7S6+RVC-;,Q[[<%?_`!UE%88W#0C!
M5:>S-L'B9RFZ53='8UD^)M4GT7PU?ZE;+&TUO%O19`2I.>^"#^M:U<YX]_Y$
M36/^O<_S%<%))SBGW1WU6U!M=CSS1/BWKVI:]IUA-:::L5S=10N4CD#!68`X
MR_7FO9J^7/"G_(XZ)_V$(/\`T8M?4==F84H4Y14%8X\!5G4BW-W/&=;^+>O:
M;KVHV$-IIK16UU+"A>.0L55B!G#]>*]0\,ZI/K7AJPU*Y6-9KB+>ZQ@A0<]L
MDG]:^<O%?_(XZW_V$)__`$8U?0'@+_D1-'_Z]Q_,UIC:-.%&,HJS_P"`9X.M
M.=649.Z_X)T=9/B;5)]%\-7^I6RQM-;Q;T60$J3GO@@_K6M7.>/?^1$UC_KW
M/\Q7GTDG.*?='H56U!M=CR[_`(71XC_Y\M*_[]2?_%U[#X?UJ#Q!H=KJ5N1B
M9`74'.Q_XE/T-?+%>C?"3Q/_`&9K3:-<RA;2^.8]QX6;@#_OH#'UVUZ^,P</
M9\U-6:/(PF,G[3EJ.Z9U?Q!^(.K>%->@L+"WLI(I+59B9T<MN+..S#CY179^
M&=4GUKPU8:E<K&LUQ%O=8P0H.>V23^M>0_&C_D<;3_L'I_Z,DKU'P%_R(FC_
M`/7N/YFN.O2A'#0FEJSLHU)RQ,XMZ(Z.BBL+QEK1T#PGJ&H(<3+'LAY&=[':
MI]\$Y^@-<48N4E%=3LE)1BY/H<YXR^)]KX=NFT_3X$O;Y.)"6Q'$?0XY)]AC
M'KVK@S\7_%!G\P?8@N<^6(#M^G7./QKC=/L[C6-6M[.(E[BZF"!FR>6/4_S)
MKWQ/A=X572Q9-8LSX&;GS&\PMC[V<X'TQCVKV)PPV%2C-7;/)A/$XEN4'9(R
M?!_Q6@UN\CT_5X(K.ZDXCE1CY3MV7!Y4GMR<UZ17RKK6FRZ'KMYISD[[:8H&
MZ$@'Y6_$8/XU]$>!M:?7O!]A>3.7N`IBF8]2ZG&3[D`'\:YL;AH02J4]F=&"
MQ,YMTZFZ.BK)\3:I/HOAJ_U*V6-IK>+>BR`E2<]\$']:UJYSQ[_R(FL?]>Y_
MF*XJ23G%/NCMJMJ#:['GFB?%O7M2U[3K":TTU8KFZBA<I'(&"LP!QE^O->S5
M\N>%/^1QT3_L(0?^C%KZCKLS"E"G**@K''@*LZD6YNX4445YYWA7G_C+XGVO
MAVZ;3]/@2]ODXD);$<1]#CDGV&,>O:NC\9:T=`\)ZAJ"'$RQ[(>1G>QVJ??!
M.?H#7S=I]G<:QJUO9Q$O<74P0,V3RQZG^9->C@<+&HG4J;(\_&XF5.T(;L[(
M_%_Q09_,'V(+G/EB`[?IUSC\:[3P?\5H-;O(]/U>"*SNI.(Y48^4[=EP>5)[
M<G-:R?"[PJNEBR:Q9GP,W/F-YA;'WLYP/IC'M7@^M:;+H>NWFG.3OMIB@;H2
M`?E;\1@_C733AA<2G&$;-'/.6)PS4IRNF?55%<[X&UI]>\'V%Y,Y>X"F*9CU
M+J<9/N0`?QKHJ\><7"3B^AZT)*<5)=0KS_QE\3[7P[=-I^GP)>WR<2$MB.(^
MAQR3[#&/7M71>,]:;0/"5_J$;`3JFR'UWL0H(]<9S^%?.&E:?-K.LVEA$V);
MJ98][<XR>6/TZUWX+"QJ)U*FR.'&XF5-JG3W9V)^+_B@S^8/L07.?+$!V_3K
MG'XUVOA#XK6^MWL>GZM!'9W4G$<J-^[=O3GE2>W)]*UH_AAX572ULGL"[A<&
MY,C"0MC[V<XSWQC'M7B.K^&-0T[7[S2X+:XNC!-Y2O'"QWYP5X`ZD$''O71"
M.%Q*<8JS1SSEBL.U*3NF?3]%8WA2ZOKSPMI\VI0S0WOE;9EG0H^Y25R0>><9
M_&MFO(E'E;78]>,N9)E#6[V33=!U&_A5&EMK669`X)4LJDC..W%>0V7QA\0W
M-_;P/9Z8%EE5"1%)G!(']^O5O%?_`")VM_\`8/G_`/1;5\SZ5_R&+'_KXC_]
M"%>E@*-.I"3DKGFXZM.$XJ+L?5]%%%>6>F<9\1/%M_X2L+*>PAMI&GE9&$ZL
M0`!GC#"O/O\`A='B/_GRTK_OU)_\771_&S_D#Z5_U\/_`.@UQ7PQT'3?$/B2
MXM-5MOM$"6;2JN]DPP=!G*D'H37L8:E16&]I.-SR<14K/$>SA*QI?\+H\1_\
M^6E?]^I/_BZZ3P-\1]8\3>)4TV]MK&.%HG<M"CAL@>[$?I71?\*P\'?]`?\`
M\F9O_BZO:1X(\.Z%?B]TW3_(N`I4/YTC<'KPS$5A4KX1P:C"S_KS-J='%*:<
MIZ?UY'0445!>3FVL;BX4!C%&S@'O@9KSDKGH/0X7QI\3[;P[<OIVFPI>7Z<2
M,S?NX3Z''+'U`(QZYXK@C\7O%)E+AK,*3G8(.![=<X_&N&EEDGF>:5R\DC%G
M8]23R37O6B>&_AYJNGPPZ?#979:/!W3'S^0>6&0P/![#VKVYTJ&%@N:/-YGC
M0JU\3-\LK>1F>%_B]#J-W'9:W:QVLDK!4N(2?+R3C#`\J/?)_#K7J%>-M\%K
MF36;@+J,4&F!_P!RQ!>4KC/(X'MG/;.*];TZS_L_3+6R,SS?9XEB\R3[S[1C
M)]^*X,6J%TZ+^1W85U[-55\RS1117&=84444`%%%%`!1110!XM\;/^0SI?\`
MU[M_Z%5SX'_\Q[_MW_\`:E4_C9_R&=+_`.O=O_0J/@[JVG:9_;7]H:A:VGF>
M1L^T3+'NQYF<9(SC(_.O9:;P%E_6IXZ:6.N_ZT/6M<$3>']2$^WRC:RA]QP-
MNPYS[8KY4KV;XB_$33I=$FTC1;H7,UT-DTT6=J1]QGN3TX[$^U>:^$=#D\0^
M)K.P5<QEP\QQP(UY;_#ZD5>`@Z-*4YZ$XZ:JU8PAJ?2]F9FL;<W&?/,:F3(Q
M\V.?UJ>BBO#9[2"OF_X@^&O^$:\3S11*!9W.9[<#^%2>5_`Y'TQ7TA7BWQL_
MY#.E_P#7NW_H5=^73:K<JV9P9A!.CS/='.?#KPT/$?BB)9XP]E:_OIP1D-C[
MJGZGMZ`U]&5Y%\#_`/F/?]N__M2O7:68S<JSB]D/+X*-%274****X3N/ES_F
M</\`M_\`_:E;/Q'\+_\`"-^)':",+87F9;<*,!>?F3\"?R(K&_YG#_M__P#:
ME?07C7PVOBCPW/9+@7*?O;9CVD`X'T/(_'/:O?KU_8U(-[-:GA4:'MJ<TMUL
M>%3^)FO/A_%H%RY:6TOEEMR1_P`LBD@(S[,1_P!]>U>B_!/_`)`^J_\`7PG_
M`*#7C$D;PRO%*C)(A*LK#!4CJ".QKV?X)_\`('U7_KX3_P!!HQL%'#RMU88*
M3E7C?HCU&BBD)"J68@`<DGM7@'NGB_QIU7SM6T_2D;Y;>(S.!_>8X'Y!?_'O
MRN^!O"HO_A;K&4)GU/=Y78'R_P#5_P#CX-><>)-3?Q!XIOK]`7^T3D1``Y*C
MY4&/7`%'_"*>(_\`H`:K_P"`<G^%?0*ART(T^;E>C_7\SP/;7K2J<MUM^GY&
M?9W4MC?6]Y`0)8)%E0GLRG(_45]66-W'?V%M>1?ZN>)94^C`$?SKY3N[*[T^
M<P7MK-;3``F.:,HV#WP>:]W^$NK'4/!JVKG,EC*T/3JI^93^I'X5CF=/FIJH
MNAMEL^6;@^IWE%%%>*>R?./Q)TK^RO'-^`"([HBZ3.>=_+=?]K=76^%_%/V3
MX/ZLC2`3V1:WBR0?];]W'K@LW'/W?2K?QJTDR66G:O&G,3M;RD#/#<KGT`(;
M_OJO(4NIDM);57(AE=7=0>"5#`?^A&O?I16)P\;]+?@>#5D\/7E;K?\`$ZWX
M7:2-4\;VKNFZ*S4W+<<9'"_^/$'\*^AZ\P^"^E>1HU_JC@;KF41)TX5!S],E
MO_'17I]>;F%3GK-=M#T<!3Y**??4*HZSJ*:1HM[J#XQ;0M)@C.2!P/Q.!5ZO
M-_C)J_V3PW;Z8C#S+V7+#_IFF"?_`![;^1KGH4_:5%#N=%>I[.FY=CR?PSIS
M>(/%UA9S$N+BX#3'N5'S/^@-=9\8]*^R>*8-05<)>P#<?5T^4_\`CNRN&L='
MU34T=[#3;R[5#AF@@:0*?0X'%37'AS7+2!Y[G1M1AA09>22U=54>I)&!7T,H
MKVJES;:6/`C)^R<>7?6YZ3\%-5.[4](8C&!=1C\E;_V2O7J^9O`VK'1?&6FW
M1.(VE$,G&?E?Y2?PSG\*^F:\C,:?+6YNYZV7U.:ER]@HHKG/&_B5?"_AR:\1
MD^UO^[MD;NY[X]`.?_UUQ0@YR48[L[)S4(N3V1Y!\5[K3[KQM-]B0^;%&L=T
MX/#R#T]P,`_3';GG?"]U867B?3KG5(C)9QS!I%]/0GU`."1W`Q5OP?X?F\5^
M)X+1][0[O.NY">0@///J>GU.:B\7>'I?#'B.XTY\F+_60/\`WXST/U'(/N#7
MTD.2*^KWUL?/3YY/V]M+GTZ"&4,I!!Y!'>EKSOX3>*/[5T0Z/<R`W=@H$>3R
M\/0?]\_=^FVO1*^=K4G2FX/H>_2J*I!374****S-`HHHH`*R/%?_`")VM_\`
M8/G_`/1;5KUD>*_^1.UO_L'S_P#HMJNG\:]2*GP,^9]*_P"0Q8_]?$?_`*$*
M^KZ^4-*_Y#%C_P!?$?\`Z$*^KZ]/-=X_,\[+-I?(****\D]0^?\`XN?\CW+_
M`->\?\JY.R_M7R3]A^V^5NY\C=MW?AWZ5UGQ<_Y'N7_KWC_E72?"OQ-HNB^&
M+FVU+48;:9KUI`DA.2I1!G\P?RKZ"-1T\-&2C?1'@RIJIB91;MJSSC_BHO\`
MJ*?^1*^HZYS_`(3WPK_T'+7\S_A6II>MZ;K<4DFFWD=RD9VN8ST->9BZLZJ3
M<+6/1PM*%)M*=[E^O/\`XQ-*/!*",95KR,2<=%VM_7;7H%<WX]T=];\&:A:Q
M#,Z()HAR<LAW8`'<@$?C6&'DHU8M]S?$1<J4DNQX1X(CCD\;Z,LH&T72,,G'
M(.1^H%?3=?)VG7KZ;JEI?1J&>VF290>Y5@1_*OI*S\:^'+W3!?IJ]K'$%#.L
MLJJZ$]BI.<]?KCC->AF=.3E&26AP9;4BHRBV:;Z3ITES)<OI]JT\N/,E:%2S
MX&!DXR<#BK$%O!;(4@ACB0G)6-0HSZ\5\]^+/'FI:IXCN;C2=4O[6P!"0I%<
M/&&`&-Q`/4G)_*O6OALVJ2^#H+G5;F>XFN':2-IV+,(^`O)YQP3SZURUL+.E
M34Y/?H=-'%0J5'"*^9UU<YX]_P"1$UC_`*]S_,5T=<YX]_Y$36/^O<_S%<]'
M^)'U1T5OX<O1GS7%YGG)Y._S=PV;,[MW;&.]:G_%1?\`44_\B4>%/^1QT3_L
M(0?^C%KZCKW,7BO822Y;W/%PF%]M%OFM8^2)?,\Y_.W^;N._?G=N[YSWKZ4\
M!?\`(B:/_P!>X_F:^?\`Q7_R..M_]A"?_P!&-7T!X"_Y$31_^O<?S-8YB[T8
MO^MC;+E:M)?UN='7.>/?^1$UC_KW/\Q71USGCW_D1-8_Z]S_`#%>31_B1]4>
MI6_AR]&>+?#G3+?6?$LFG7:!H;BTE1N.G`P1[@X(]Q6!JVFW>@:W<6%P2ES:
MR8W*2,]U8>Q&"/K75_"/_D>XO^O>3^5=E\7O"YOM.CUZU0F>T&RX51RT6>&_
MX"3^1)[5[DJ_)B>1[-?B>+&ASX;G6Z?X'FWC#Q'_`,)/<Z9>N?\`28[!(;GY
M<#S%=\D?4$'CUQ7NG@+_`)$31_\`KW'\S7S17TOX"_Y$31_^O<?S-89C!0HQ
MBMKFV7S<ZLI/>QT=<+\7/^1$E_Z^(_YFNZKGO'.C2:[X/U"RA3?<;!)".Y93
MNP/<X(_&O,P\E&K%ON>G7BY4I)=CP[X=)$_C_2!,Y5?,8@C^\$8J/Q.!7TE7
MRGHNI/HVMV6HQC<;:99-O]X`\C\1D5]'1>-/#DNEKJ/]L6B0$`D/*`ZG&=I7
MKN]L5Z&9TY.<9)'!EU2*A*+9XC\3_P#DHNJ_]L?_`$4E>C_!@D^#KH$D@7[@
M>W[N.O'O$>K'7?$5_J9#!;B4L@;J$Z*#R>0`*]\^'.DOH_@FQBE4K-.#<.I[
M;N1_X[MZUIC/<PL8/?3\C/!^_B936VIU5<YX]_Y$36/^O<_S%='7.>/?^1$U
MC_KW/\Q7DT?XD?5'J5OX<O1GS_X4_P"1QT3_`+"$'_HQ:^HZ^6/#EQ%:>)])
MN9W$<,5[#)(YZ*H<$G\J^A/^$]\*_P#0<M?S/^%>GF4)2G'E5SSLNG&,9<SL
M='163I?B;1=:N6MM-U&&YF5#(4C)R%!`S^9'YUK5Y,HN+LU8]2,E)73.%^+G
M_(B2_P#7Q'_,UY1\.5B;X@:0)CA/,8CG^((Q7]<5[AXYT:37?!^H64*;[C8)
M(1W+*=V![G!'XU\Z:+J3Z-K=EJ,8W&VF63;_`'@#R/Q&17L8'W\/*"WU_%'D
M8WW,1&;VT_!GU97SG\3_`/DHNJ_]L?\`T4E>W1>-/#DNEKJ/]L6B0$`D/*`Z
MG&=I7KN]L5\[^(]6.N^(K_4R&"W$I9`W4)T4'D\@`5GEM.<:DI-=+&F8U(NF
MDGU/8?@P2?!UT"20+]P/;]W'7HM<K\.=)?1_!-C%*I6:<&X=3VW<C_QW;UKJ
MJX<3)2K2:[G=AHN-**?8\]^,DDB>"X50G:]ZBOQGC:Y_F!7FOPQ`;XB:4"`1
M^]//_7)Z]C^(NE2:OX(OXH0S2P@3HJ_Q;#DCWXS^.*^?]`U:30M>LM3C!8V\
MH9E!P67HRY]P2/QKT\%[^%E!;Z_D>;C/<Q,9O;0]H^(GCK5/"5_906$%G(D\
M1=C.C$@@XXPPKC/^%T>(_P#GRTK_`+]2?_%UW^J/X"\5VD.J:G=V<\<285GN
MVB9`><%0P.?8C->%:Y)ITNMW;:3#Y.G^81`F6/RC@'YB3SC//K2P=*E./+*&
MJW;#%U:L)<T9Z/:Q]&^#=:N?$/A2RU6[2))Y]^Y8@0HVNRC`))Z`=ZW:Y'X8
M?\DZTK_MM_Z->NNKRZZ4:LDN[/4HMRIQ;[(R/%?_`")VM_\`8/G_`/1;5\SZ
M5_R&+'_KXC_]"%?3'BO_`)$[6_\`L'S_`/HMJ^9]*_Y#%C_U\1_^A"O4RW^'
M,\S,?XD3ZOHHHKQCUSR[XV?\@?2O^OA__0:\?LOMOG'[#]H\W;SY&=VW\.W2
MO8/C9_R!]*_Z^'_]!KC_`(5ZOI^B^)[FYU*ZCMH6LFC#R="Q=#C\@?RKW<))
MPPG,E??\SP\5%2Q7*W;8YW_BHO\`J*?^1*]Z^'/VG_A`]-^U^;Y_[W=YN=W^
MM?&<\],5-_PGOA7_`*#EK^9_PJWIWBK0M7NQ:Z?J<%Q.06"(3G`ZUQ8FO4JP
MLX6MJ=N&HPI3NIWN;%%%9?B+5WT'0+O5$M&NC;J'\E6V[AD`G.#@`$GIVK@C
M%R:2.Z344VSQ+QA\-M4T.^EFTVVFO-,;+(T2[FB']U@.>/7I7#D%6((((X(/
M:O5;'XSWDNM6XO;&V@TPOB7RPS2*"",YS@X.#T[5Z'=7/A'6K(W%Y/H]U`1D
MR3/&=O'J>5(S[$5[?UJM12C6C?S1XWU:C6;=*5O)GAGA[QYKOAZXB,=Y+<6J
M\-:SN60KGD#/W3[BOH;1]5M];T>UU*T),-P@<`]5/0J?<$$'Z5\Q:VFGQZW>
MKI3L]@)6$#-G)7MUYQ]:][^%]K-:^`=/\XOF4R2*K#[JESC'L?O?\"K/,:<.
M15$K,TR^I/G=-NZ.PHHHKQSU@HHHH`****`"BBB@#S#XH^$M<\1ZE83:59?:
M(XH65SYJ)@DY_B(K@O\`A6'C'_H#_P#DS#_\77T917=2Q]2G!025E_7<XJN!
MIU)N;;U_KL>!V'PA\373+]J%K9(1EC)*'(Y]%SSWZUZWX4\'Z=X2LFBM-TEQ
M+CSKA_O28SCCH`,]!^M=#16=;&5:RM)Z&E'"4J3O%:A1117*=(5YA\4?"6N>
M(]2L)M*LOM$<4+*Y\U$P2<_Q$5Z?16M&K*E/GCN95J4:L.21YS\*_"^L^&_[
M6_M:S^S_`&CR?*_>H^[;OS]TG'WAUKT:BBE6JNK-SENQTJ2I04([(****S-#
MP7_A7/BO_A)/M?\`97[C[9YN[[1%]W?G.-V>E>]445T5\1*M;FZ&%##QHWY>
MIY#\0_AQJ6H^(/[2T&T$ZW0+7$?F(FR0=_F(X8?7D'U%=#\+O#FK>'--OX=5
MM?L[RS*R#S%?(`Q_"37>T54L74E2]D]OQ)CA81J^U6X5D^)TU"7PSJ$6E0>=
M>RPF.)-P7EOE)R2!P"3U[5K45S1?*TSHDKIH\1\&_#?Q!9^+-/O-5T\06EO)
MYS.9HV^91E0`K$_>Q7MU%%;5\1.O+FD94*$:,>6)YA\4/!.J>(-1L;_1[07$
MHB,4X\Q4(`.5/S$`]6_*H_ACX9\2^&=9NQJ6G>397,(#/YT;8=3\O"L3T+=N
M]>IT5?UN?LO8M*Q'U2'M?:INX4445RG28?B_13X@\*W^G(H:9X]T.<?ZQ>5Y
M/3)&,^A->'_\*P\8_P#0'_\`)F'_`.+KZ,HKJH8RI0BXQL<M?"4ZTN:5S(\+
MZ3_8?AC3M-90LD,($@!R/,/+X/IN)K7HHKFE)R;D^ITQBHI)=`KR/XD>%/%/
MB7Q,);'3/-LH(5CB?SXUW'[S'!8'J<=.U>N45K0K2HRYXK4SK456CRR>ARWP
M^\/W'AOPG#9WD8CNY)'FF0,&PQ.`,C@_*%KH-1LH]2TRZL9L>7<1-$V1GAAB
MK-%1.I*4W-[E1@HP4%L?.A^%_C$,0-(!`[BYBY_\>KW[1VO7T:S.I1>5>^2H
MG3<&P^.>02.OO5VBML1BIUTE)+0QH86%!MQ;U"O'_B!X:\8>*?$+26^E.=/M
MAY=L#<Q#(_B?!?C<?QP!FO8**BA6=&7-%*_F76HJM'ED]#C?ASX1?POH;->1
MA=2NCNG&X-L`)VJ"..G/U/M3/B1X1D\3Z+')8PJ^I6S9B&0I=3]Y<G`]^?3W
MKM:*/K$_:^UZA["'LO9=#P?P]X*\<^'M=M=3M](.Z%OG7[5#AT/#*?G[C_&O
M=T8LBL5*$C)4XR/;CBEHJJ^(E7:<DKBH8>-%-1;"BBBN<W"BBB@`K.\06LU]
MX;U6TMDWSSV<L4:Y`W,R$`9/`Y-:-%.+L[B:NK'SYI_PT\70:E:S2:3M1)D9
MC]IB.`""?XJ^@Z**WQ&)G7:<NAA0PT*%U'J%%%%<YT'C_P`1?!'B+7?%DE[I
MNG^?;F%%#^=&O('/#,#7)_\`"L/&/_0'_P#)F'_XNOHRBN^GF%6$5%):?UW.
M&>`I3DY-O7^NQ\Y_\*P\8_\`0'_\F8?_`(NO3_A=X<U;PYIM_#JMK]G>6960
M>8KY`&/X2:[VBHK8ZI5AR22L51P5.E/GBV%%%%<9V'EGC'X3G4;V74=!DBAD
ME.Z2UDX4MW*GMGTZ>_:N`?X=>+8YQ"=%F+'`!5T*\_[0./UKZ2HKNI9A5A'E
MW.*I@*4WS;'BWAKX/WTUPD_B!TM[=2";:)PSO[$C@#Z$GZ=:]GCC2&)(HD5(
MT`5548"@=`!V%.HK"OB)UG>9O1P\**M`*Q?%UA<ZIX3U*RLXO-N)H2L:;@N3
MD=S@5M45E&3C)270TE%2BXOJ>"^'_ASXKL?$FE7=SI6R""\BED;[1$=JJX).
M`V3P*]ZHHK;$8B5=IRZ&5##QH)J/4\%\0?#GQ7?>)-5N[;2M\$]Y++&WVB(;
ME9R0<%LC@U[!X1L+G2_">FV5Y%Y5Q#"%D3<&P<GN,BMJBG6Q4ZL%"26A-'"P
MI2<XMZA6+XNL+G5/">I65G%YMQ-"5C3<%R<CN<"MJBL(R<9*2Z&\HJ47%]3Q
M_P"'7@CQ%H7BR.]U+3_(MQ"ZE_.C;DCCA6)KUV6*.>%X94#QR*5=3T(/!%/H
MK2O7E6GSRW,Z-"-&/+'8\!UCX5>(H-8NH]+L#<V(<F"4SQJ2IY`(+`Y'0\=J
M]D\(V%SI?A/3;*\B\JXAA"R)N#8.3W&16U15UL74K149="*.%A1DY1ZA1117
M,=)Y3XU^%,E_>R:EX?,2/*=TMHYV@L>I0]!GT.!Z'M7!GX=>+1<>0=%FW],A
MT*_]]9Q^M?25%=U/,*L(\NYPU,!2G+FV/(_!_P`))8+J'4/$+Q_NR'6RC.[)
M[;V'''H,Y]>U>N445SUJ\ZTN:;.FC0A1C:`5B^+K"YU3PGJ5E9Q>;<30E8TW
M!<G([G`K:HK.,G&2DNA<HJ47%]3YS_X5AXQ_Z`__`),P_P#Q='_"L/&/_0'_
M`/)F'_XNOHRBN_\`M.MV7X_YG#_9M+N_P_R/*/ACX-U_P]XDN+O5;#[/`]FT
M2MYT;Y8NAQA6)Z`UZO117'6K2K3YY'71HQHQY8A7E/C7X4R7][)J7A\Q(\IW
M2VCG:"QZE#T&?0X'H>U>K444:TZ,N:`5J,*L>69\VGX=>+1<>0=%FW],AT*_
M]]9Q^M=MX/\`A)+!=0ZAXA>/]V0ZV49W9/;>PXX]!G/KVKURBNJIF-:<>5:'
M-3R^E"5WJ%%%%<!W!7D'B_X23RWLE[X<$7EO\S6;-MVM_L$\8]CC'TZ>OT5M
M1KSHRYH&-:A"M&TSYN7X<^+6G,(T67>.YD0+_P!];L?K713_``>U6#PXTZ2)
M<:L9%*VT3@($YR-S8!;D'TX/7->WT5U2S*L[6LCFCEU)7O=G.>`]+O-&\%Z?
MI^H0^3=1>9OCW!L9D9AR"1T(KHZ**X9R<Y.3ZG;"*A%170SO$%K-?>&]5M+9
M-\\]G+%&N0-S,A`&3P.37ANG_#3Q=!J5K-)I.U$F1F/VF(X`()_BKZ#HK>AB
MIT8N,4M3"MA85FI2;T"BBBN8Z3@OBCX<U;Q'IMA#I5K]H>*9F<>8J8!&/XB*
M\P_X5AXQ_P"@/_Y,P_\`Q=?1E%=E''5*4.2*5CCK8*G5GSR;/G/_`(5AXQ_Z
M`_\`Y,P__%UUGPZ\$>(M"\61WNI:?Y%N(74OYT;<D<<*Q->P45=3,*LXN+2U
M_KN3#`4H24DWI_78*9+%'/"\,J!XY%*NIZ$'@BGT5P'<>+>)?@_?0W#S^'W2
MXMV)(MI7"NGL">"/J0?KUKE?^%=^+?/\G^Q9]^<9WIM_[ZSC]:^DZ*]"&95H
MJSLS@GEU*3NKH\6\-?!Z_FN8Y_$$B6]NI!-M&^YY/8L.%'N"3].M>S111P0I
M#$@2.-0J*.@`X`I]%<U?$5*SO,Z:.'A15H!1116!L%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
..4444`%%%%`!1110!_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
